Diabetologia

Papers
(The H4-Index of Diabetologia is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]598
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]319
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study253
Up Front243
58th EASD Annual Meeting of the European Association for the Study of Diabetes210
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study180
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification150
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT145
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes145
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin142
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq135
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care121
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells107
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities97
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people97
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study94
60th EASD Annual Meeting of the European Association for the Study of Diabetes92
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory85
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes81
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo81
In Memoriam Werner Waldhäusl, 27 September 1937–22 May 202579
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study77
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study73
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway73
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation72
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes70
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy68
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study68
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials66
Ageing well with diabetes: the role of technology65
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)64
Pinpointing precision medicine for diabetes mellitus63
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk62
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults62
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women61
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study61
Mortality risk for kidney transplant candidates with diabetes: a population cohort study59
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial59
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes59
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis59
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial58
Up Front57
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications57
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy56
Daniel Porte Jr, 13 August 1931–13 May 202355
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open55
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap54
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity54
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome53
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals53
Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics51
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes51
0.12964606285095